{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:49:49Z","timestamp":1780080589914,"version":"3.54.0"},"reference-count":181,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","cgfr.co.uk","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.cytogfr.2016.11.001","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T01:01:57Z","timestamp":1479862917000},"page":"19-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Cytokine signatures in hereditary fever syndromes (HFS)"],"prefix":"10.1016","volume":"33","author":[{"given":"Jos\u00e9 Noel","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"J\u00e9ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Lecron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrna","family":"Medlej-Hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2016.11.001_bib0005","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00130832-200212000-00006","article-title":"The autoinflammatory syndromes","volume":"2","author":"McDermott","year":"2002","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0010","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0015","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s00393-012-1061-1","article-title":"Genetic fever syndromes. Hereditary recurrent (periodic) fever syndromes","volume":"72","author":"Neudorf","year":"2013","journal-title":"Z.F\u00fcr Rheumatol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0020","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1073\/pnas.0708616105","article-title":"Mutations in NALP12 cause hereditary periodic fever syndromes","volume":"105","author":"J\u00e9ru","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0025","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1002\/art.38727","article-title":"Brief report: involvement of TNFRSF11A molecular defects in autoinflammatory disorders","volume":"66","author":"J\u00e9ru","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejmhg.2011.07.005","article-title":"Hereditary periodic fever syndromes","volume":"12","author":"Shawky","year":"2011","journal-title":"Egypt. J. Med. Hum. Genet."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0035","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/ar2579","article-title":"Developments in the scientific and clinical understanding of autoinflammatory disorders","volume":"11","author":"Lachmann","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0040","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.cyto.2014.06.012","article-title":"Ex vivo PBMC cytokine profile in familial Mediterranean fever patients: involvement of IL-1\u03b2, IL-1\u03b1 and Th17-associated cytokines and decrease of Th1 and Th2 cytokines","volume":"69","author":"Ibrahim","year":"2014","journal-title":"Cytokine."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0045","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/annrheumdis-2012-202774","article-title":"Increased NLRP3-dependent interleukin 1\u03b2 secretion in patients with familial Mediterranean fever: correlation with MEFV genotype","volume":"73","author":"Omenetti","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0050","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.clinbiochem.2008.03.017","article-title":"Cytokine profile of Armenian patients with familial Mediterranean fever","volume":"41","author":"Manukyan","year":"2008","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0055","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00296-006-0301-6","article-title":"Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever","volume":"27","author":"Simsek","year":"2007","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0060","first-page":"S77","article-title":"Serum interleukin 17 and interleukin 18 levels in familial Mediterranean fever","volume":"23","author":"Haznedaroglu","year":"2005","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10067-002-0682-1","article-title":"Serum sIL-2r, IL-6 IL-10 and TNF-alpha level in familial Mediterranean fever patients","volume":"22","author":"Baykal","year":"2003","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0070","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10067-004-0925-4","article-title":"Continuity of cytokine activation in patients with familial Mediterranean fever","volume":"23","author":"Bagci","year":"2004","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0075","first-page":"S34","article-title":"Levels of interleukin-6 (IL-6) and its soluble receptor (sIL-6R) in familial Mediterranean fever (FMF) patients and their first degree relatives","volume":"22","author":"Oktem","year":"2004","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0080","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s00296-005-0099-7","article-title":"Plasma interleukin-10 and interleukin-12 levels in patients with familial Mediterranean fever","volume":"26","author":"Erken","year":"2006","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0085","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1182\/blood.V85.12.3586.bloodjournal85123586","article-title":"Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome","volume":"85","author":"Drenth","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0090","first-page":"400","article-title":"Unstimulated peripheral blood mononuclear cells from patients with the hyper-IgD syndrome produce cytokines capable of potent induction of C-reactive protein and serum amyloid A in Hep3B cells","volume":"157","author":"Drenth","year":"1996","journal-title":"J. Immunol. Baltim. Md. 1950"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0095","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/cei.12361","article-title":"Impaired cytokine responses in patients with cryopyrin-associated periodic syndrome (CAPS)","volume":"177","author":"Haverkamp","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0100","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1002\/art.10688","article-title":"De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases","volume":"46","author":"Aksentijevich","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00296-009-0937-0","article-title":"Tumor necrosis factor receptor 1-associated periodic syndrome without fever: cytokine profile before and during etanercept treatment","volume":"30","author":"Morbach","year":"2009","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0110","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1365-2249.2004.02632.x","article-title":"Does immune activation continue during an attack-free period in familial Mediterranean fever?","volume":"138","author":"Musabak","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0115","doi-asserted-by":"crossref","first-page":"A82","DOI":"10.1136\/annrheumdis-2011-201238.23","article-title":"Comparative cytokine analysis across a spectrum of genetically and\/or clinically defined auto-inflammatory syndromes","volume":"71","author":"Kontzias","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0120","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/pr.2013.96","article-title":"Mouse model of mevalonate kinase deficiency: comparison of cytokine and chemokine profile with that of human patients","volume":"74","author":"Marcuzzi","year":"2013","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0125","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/nm1209-1363","article-title":"Immune modulation: IL-1 master mediator or initiator of inflammation","volume":"15","author":"Mills","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0130","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0135","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0140","doi-asserted-by":"crossref","first-page":"e20014","DOI":"10.1371\/journal.pone.0020014","article-title":"Role of IL-1 Beta in the development of human TH17 cells: lesson from NLPR3 mutated patients","volume":"6","author":"Lasigli\u00e8","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0145","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.immuni.2009.02.007","article-title":"Critical regulation of early Th17 cell differentiation by interleukin-1 signaling","volume":"30","author":"Chung","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0150","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ni1497","article-title":"Development, cytokine profile and function of human interleukin 17-producing helper T cells","volume":"8","author":"Wilson","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0155","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMe0811014","article-title":"Interleukin-1beta and the autoinflammatory diseases","volume":"360","author":"Dinarello","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0160","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jaci.2009.11.016","article-title":"Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses","volume":"124","author":"Goldbach-Mansky","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0165","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1359-6101(02)00020-5","article-title":"The balance between IL-1 and IL-1Ra in disease","volume":"13","author":"Arend","year":"2002","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0170","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2249.2011.04535.x","article-title":"Immunology in clinic review series; focus on autoinflammatory diseases: role of inflammasomes in autoinflammatory syndromes","volume":"167","author":"Ozkurede","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0175","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-\u03b2","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol. Cell."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0180","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","article-title":"Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)","volume":"27","author":"Masters","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0185","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ni.2237","article-title":"Regulation of inflammasome signaling","volume":"13","author":"Rathinam","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0190","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mib.2014.10.008","article-title":"Antimicrobial inflammasomes: unified signalling against diverse bacterial pathogens","volume":"23","author":"Eldridge","year":"2015","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0195","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","article-title":"Mechanisms and functions of inflammasomes","volume":"157","author":"Lamkanfi","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0200","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nri2851","article-title":"Central roles of NLRs and inflammasomes in viral infection","volume":"10","author":"Kanneganti","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0205","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1600-065X.2011.01053.x","article-title":"The PYHIN protein family as mediators of host defenses","volume":"243","author":"Schattgen","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0210","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/sj.cdd.4401734","article-title":"Cryopyrin and pyrin activate caspase-1, but not NF-\u03baB, via ASC oligomerization","volume":"13","author":"Yu","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0215","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cell.2014.01.063","article-title":"Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation","volume":"156","author":"Cai","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0220","doi-asserted-by":"crossref","first-page":"13237","DOI":"10.1073\/pnas.1507579112","article-title":"Structure and assembly of the mouse ASC inflammasome by combined NMR spectroscopy and cryo-electron microscopy","volume":"112","author":"Sborgi","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0225","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.cell.2014.02.008","article-title":"Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes","volume":"156","author":"Lu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0230","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/prot.24287","article-title":"Structure of the NLRP1 caspase recruitment domain suggests potential mechanisms for its association with procaspase-1","volume":"81","author":"Jin","year":"2013","journal-title":"Proteins"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0235","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1128\/IAI.01032-08","article-title":"Anthrax lethal toxin triggers the formation of a membrane-associated inflammasome complex in murine macrophages","volume":"77","author":"Nour","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0240","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/eji.201040331","article-title":"NLR-containing inflammasomes: central mediators of host defense and inflammation","volume":"40","author":"Fitzgerald","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0245","first-page":"787","article-title":"Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J. Immunol. Baltim. Md 1950."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0250","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/imr.12296","article-title":"Regulation of inflammasome activation","volume":"265","author":"Man","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0255","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/cmi.2015.95","article-title":"Molecular mechanisms regulating NLRP3 inflammasome activation","volume":"13","author":"Jo","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0260","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.immuni.2013.08.001","article-title":"Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation","volume":"39","author":"Iyer","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0265","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","article-title":"K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter","volume":"38","author":"Mu\u00f1oz-Planillo","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0270","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0275","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0280","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/ni.1980","article-title":"Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome","volume":"12","author":"Nakahira","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0285","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","article-title":"Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis","volume":"36","author":"Shimada","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0290","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.tcb.2014.12.009","article-title":"Mechanisms of inflammasome activation: recent advances and novel insights","volume":"25","author":"Vanaja","year":"2015","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0295","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1083\/jcb.201602089","article-title":"The cell biology of inflammasomes: mechanisms of inflammasome activation and regulation","volume":"213","author":"Sharma","year":"2016","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0300","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nature02664","article-title":"Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf","volume":"430","author":"Mariathasan","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0305","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.chom.2010.11.007","article-title":"Differential requirement for caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing","volume":"8","author":"Broz","year":"2010","journal-title":"Cell Host Microbe."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0310","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1038\/ncomms4209","article-title":"Activation of the NLRP1b inflammasome independently of ASC-mediated caspase-1 autoproteolysis and speck formation","volume":"5","author":"Van Opdenbosch","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0315","doi-asserted-by":"crossref","first-page":"17254","DOI":"10.1073\/pnas.1415756111","article-title":"Caspase-1 autoproteolysis is differentially required for NLRP1b and NLRP3 inflammasome function","volume":"111","author":"Guey","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0320","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.immuni.2012.07.006","article-title":"The NLRP12 inflammasome recognizes Yersinia pestis","volume":"37","author":"Vladimer","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0325","doi-asserted-by":"crossref","first-page":"e1003885","DOI":"10.1371\/journal.ppat.1003885","article-title":"Malaria-induced NLRP12\/NLRP3-dependent caspase-1 activation mediates inflammation and hypersensitivity to bacterial superinfection","volume":"10","author":"Ataide","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0330","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1073\/pnas.1317643111","article-title":"Salmonella exploits NLRP12-dependent innate immune signaling to suppress host defenses during infection","volume":"111","author":"Zaki","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0335","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ccr.2011.10.022","article-title":"The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis","volume":"20","author":"Zaki","year":"2011","journal-title":"Cancer Cell."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0340","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.immuni.2012.03.012","article-title":"NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-\u03baB signaling","volume":"36","author":"Allen","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0345","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4049\/jimmunol.179.2.1274","article-title":"Pyrin levels in human monocytes and monocyte-derived macrophages regulate IL-1\u03b2 processing and release","volume":"179","author":"Seshadri","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0350","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature13449","article-title":"Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome","volume":"513","author":"Xu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0355","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/ni.3457","article-title":"Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS","volume":"17","author":"Park","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0360","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/humu.20080","article-title":"Infevers: an evolving mutation database for auto-inflammatory syndromes","volume":"24","author":"Touitou","year":"2004","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0365","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng756","article-title":"Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle\u2013Wells syndrome","volume":"29","author":"Hoffman","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0370","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/art.20295","article-title":"Variant chronic infantile neurologic cutaneous, articular syndrome due to a mutation within the leucine-rich repeat domain of CIAS1","volume":"50","author":"Frenkel","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0375","unstructured":"I. Aksentijevich, E.F. Remmers, R. Goldbach-Mansky, A. Reiff, D.L. Kastner, Mutational analysis in neonatal-onset multisystem inflammatory disease: comment on the articles by Frenkel et al. and Saito et al., Arthritis Rheum. 54 (2006) 2703\u20132704\u20132705."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0380","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1002\/art.21404","article-title":"Somatic mosaicism of CIAS1 in a patient with chronic infantile neurologic cutaneous, articular syndrome","volume":"52","author":"Saito","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0385","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clim.2013.03.016","article-title":"Monogenic autoinflammatory diseases: concept and clinical manifestations","volume":"147","author":"Almeida de Jesus","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0390","doi-asserted-by":"crossref","first-page":"e501305","DOI":"10.1155\/2013\/501305","article-title":"Clinical genetic testing of periodic fever syndromes","volume":"2013","author":"Marcuzzi","year":"2013","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0395","first-page":"w13602","article-title":"The autoinflammatory diseases","volume":"142","author":"Federici","year":"2012","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0400","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/513782","article-title":"Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues","volume":"2013","author":"Caso","year":"2013","journal-title":"Int. J. Rheumatol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0405","doi-asserted-by":"crossref","DOI":"10.3410\/M2-3","article-title":"Periodic fever syndrome and autoinflammatory diseases","volume":"2","author":"Dickie","year":"2010","journal-title":"F1000 Med. Rep."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0410","first-page":"1","article-title":"Rilonacept in the management of cryopyrin-associated periodic syndromes (CAPS)","volume":"3","author":"Gillespie","year":"2010","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0415","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMoa055137","article-title":"Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition","volume":"355","author":"Goldbach-Mansky","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"4 Suppl 84","key":"10.1016\/j.cytogfr.2016.11.001_bib0420","first-page":"S63","article-title":"Serum amyloid protein A concentration in cryopyrin-associated periodic syndromes patients treated with interleukin-1 beta antagonist","volume":"32","author":"Pastore","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"issue":"Suppl 11","key":"10.1016\/j.cytogfr.2016.11.001_bib0425","doi-asserted-by":"crossref","first-page":"S226","DOI":"10.1002\/art.38599","article-title":"A173: cerebrospinal fluid cytokines correlate with innate immune cells in neonatal onset multisystem inflammatory disease (NOMID) patients in clinical remission treated with anakinra","volume":"66","author":"Rodriguez-Smith","year":"2014","journal-title":"Arthritis Rheumatol. Hoboken N. J."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0430","doi-asserted-by":"crossref","first-page":"e75457","DOI":"10.1371\/journal.pone.0075457","article-title":"Cytokine profile in a cohort of healthy blood donors carrying polymorphisms in genes encoding the NLRP3 inflammasome","volume":"8","author":"Sahdo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0435","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/MCO.0b013e32833cf3bc","article-title":"Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research","volume":"13","author":"Zhou","year":"2010","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0440","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1002\/art.22842","article-title":"Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations","volume":"56","author":"Gattorno","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0445","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1136\/annrheumdis-2012-201340","article-title":"Deficient production of IL-1 receptor antagonist and IL-6 coupled to oxidative stress in cryopyrin-associated periodic syndrome monocytes","volume":"71","author":"Carta","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0450","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/art.27326","article-title":"Functional consequences of a germline mutation in the leucine-rich repeat domain of NLRP3 identified in an atypical autoinflammatory disorder","volume":"62","author":"J\u00e9ru","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0455","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/art.30241","article-title":"Identification and functional consequences of a recurrent NLRP12 missense mutation in periodic fever syndromes","volume":"63","author":"J\u00e9ru","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0460","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/art.30170","article-title":"Clinical presentation and pathogenesis of cold-induced autoinflammatory disease in a family with recurrence of an NLRP12 mutation","volume":"63","author":"Borghini","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0465","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/art.30378","article-title":"Role of interleukin-1\u03b2 in NLRP12-associated autoinflammatory disorders and resistance to anti-interleukin-1 therapy","volume":"63","author":"J\u00e9ru","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0470","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0002-9343(67)90167-2","article-title":"Familial Mediterranean fever. A survey of 470 cases and review of the literature","volume":"43","author":"Sohar","year":"1967","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0475","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(97)09408-7","article-title":"Familial Mediterranean fever","volume":"351","author":"Ben-Chetrit","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0480","first-page":"261","article-title":"Familial Mediterranean fever (FMF): from diagnosis to treatment","volume":"14","author":"Medlej-Hashim","year":"2004","journal-title":"Sant\u00e9"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0485","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0092-8674(00)80539-5","article-title":"Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium","volume":"90","author":"International FMF consortium","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0490","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0997-25","article-title":"A candidate gene for familial Mediterranean fever","volume":"17","author":"French FMF Consortium","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0495","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.ejhg.5200776","article-title":"The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever","volume":"10","author":"Gershoni-Baruch","year":"2002","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0500","first-page":"207","article-title":"The MEFV mutations and their clinical correlations in children with familial Mediterranean fever in southeast Turkey","volume":"34","author":"Ayd\u0131n Ece","year":"2013","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0505","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2350-5-4","article-title":"Amyloidosis in familial Mediterranean fever patients: correlation with MEFV genotype and SAA1 and MICA polymorphisms effects","volume":"5","author":"Medlej-Hashim","year":"2004","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0510","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/1529-0131(200101)44:1<163::AID-ANR20>3.0.CO;2-Z","article-title":"The MICA region determines the first modifier locus in familial Mediterranean fever","volume":"44","author":"Touitou","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0515","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/art.22507","article-title":"Country as the primary risk factor for renal amyloidosis in familial mediterranean fever","volume":"56","author":"Touitou","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0520","first-page":"1136","article-title":"Identification of MEFV-independent modifying genetic factors for Familial Mediterranean Fever","volume":"67","author":"Cazeneuve","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0525","doi-asserted-by":"crossref","first-page":"332ra45","DOI":"10.1126\/scitranslmed.aaf1471","article-title":"Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation","volume":"8","author":"Masters","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0530","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/1568010053622984","article-title":"Pharmacological and clinical basis of treatment of familial Mediterranean fever (FMF) with colchicine or analogues: an update","volume":"4","author":"Cerquaglia","year":"2005","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0535","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1542\/peds.2006-1434","article-title":"Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement","volume":"119","author":"Kallinich","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0540","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3899\/jrheum.100718","article-title":"Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine","volume":"38","author":"Ozen","year":"2011","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0545","first-page":"489","article-title":"Anakinra suppresses familial Mediterranean fever crises in a colchicine-resistant patient","volume":"66","author":"Mitroulis","year":"2008","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0550","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.semarthrit.2010.11.003","article-title":"Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature","volume":"41","author":"Meinzer","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0555","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/ard.2007.071498","article-title":"Effective treatment of a colchicine-resistant familial Mediterranean fever patient with anakinra","volume":"66","author":"Kuijk","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0560","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1007\/s00296-010-1474-6","article-title":"Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever","volume":"32","author":"Alpay","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0565","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/sj.cdd.4402142","article-title":"The SPRY domain of Pyrin mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1\u03b2 processing","volume":"14","author":"Papin","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0570","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1097-2765(03)00056-X","article-title":"Targeted disruption of pyrin the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis","volume":"11","author":"Chae","year":"2003","journal-title":"Mol. Cell."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0575","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.immuni.2011.02.020","article-title":"Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1\u03b2 activation and severe autoinflammation in mice","volume":"34","author":"Chae","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0580","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.imbio.2012.10.007","article-title":"Activated phenotype of circulating neutrophils in familial Mediterranean fever","volume":"218","author":"Manukyan","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0585","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/rheumatology\/kei279","article-title":"Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations","volume":"45","author":"Lachmann","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0590","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/08860220701810364","article-title":"The relationship between the MEFV genotype clinical features, and cytokine-inflammatory activities in patients with familial mediterranean fever","volume":"30","author":"Colak","year":"2008","journal-title":"Ren. Fail"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0595","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jbspin.2004.03.011","article-title":"Interferon-gamma levels in familial Mediterranean fever","volume":"72","author":"K\u00f6kl\u00fc","year":"2005","journal-title":"J. Bone Spine Rev. Rhum."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0600","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/sj.gene.6363813","article-title":"Enhanced cytokine mRNA levels in attack-free patients with familial Mediterranean fever","volume":"3","author":"Notarnicola","year":"2002","journal-title":"Genes Immun."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0605","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/sj.ejhg.5200725","article-title":"Familial Mediterranean Fever: association of elevated IgD plasma levels with specific MEFV mutations","volume":"9","author":"Medlej-Hashim","year":"2001","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0610","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ejmg.2015.11.007","article-title":"Study of the association of IL-1\u03b2 and IL-1RA gene polymorphisms with occurrence and severity of Familial Mediterranean fever","volume":"58","author":"Ibrahim","year":"2015","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0615","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0140-6736(84)92505-4","article-title":"Hyperimmunoglobulinaemia D and periodic fever: a new syndrome","volume":"1","author":"van der Meer","year":"1984","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0620","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/sj.ejhg.5200614","article-title":"Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome","volume":"9","author":"Cuisset","year":"2001","journal-title":"Eur. J. Hum. Genet. EJHG"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0625","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/9696","article-title":"Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group","volume":"22","author":"Drenth","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0630","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s10545-005-0178-7","article-title":"Retinitis pigmentosa in mevalonate kinase deficiency","volume":"28","author":"Balgobind","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0635","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1016\/j.ophtha.2013.07.052","article-title":"Mutations in the mevalonate kinase (MVK) gene cause nonsyndromic retinitis pigmentosa","volume":"120","author":"Siemiatkowska","year":"2013","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.cytogfr.2016.11.001_bib0640","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1002\/art.39763","article-title":"The phenotype and genotype of mevalonate kinase deficiency: a series of 114 cases from the Eurofever Registry","volume":"68","author":"Ter Haar","year":"2016","journal-title":"Arthritis Rheumatol. Hoboken N. J."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0645","doi-asserted-by":"crossref","first-page":"A142","DOI":"10.1186\/1546-0096-11-S1-A142","article-title":"PW02-002\u2014single MVK mutation and recurrent fevers","volume":"11","author":"Barron","year":"2013","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0650","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00296-014-3115-y","article-title":"GRID2 a novel gene possibly associated with mevalonate kinase deficiency","volume":"35","author":"Moura","year":"2015","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0655","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.11218","article-title":"Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome","volume":"48","author":"Takada","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0660","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00296-006-0164-x","article-title":"Treatment with anakinra in the hyperimmunoglobulinemia D\/periodic fever syndrome","volume":"27","author":"Rigante","year":"2006","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0665","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/clin.1995.1126","article-title":"Elevated serum level and altered glycosylation of alpha 1-acid glycoprotein in hyperimmunoglobulinemia D and periodic fever syndrome: evidence for persistent inflammation","volume":"76","author":"Havenaar","year":"1995","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0670","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2362.1995.tb01986.x","article-title":"Interferon-gamma and urine neopterin in attacks of the hyperimmunoglobulinaemia D and periodic fever syndrome","volume":"25","author":"Drenth","year":"1995","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0675","article-title":"Mechanisms of inflammation in mevalonate kinase deficiency","author":"Kuijk","year":"2008","journal-title":"Utrecht University"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0680","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1365-2567.1996.d01-672.x","article-title":"Immunoglobulin D enhances the release of tumor necrosis factor-alpha, and interleukin-1 beta as well as interleukin-1 receptor antagonist from human mononuclear cells","volume":"88","author":"Drenth","year":"1996","journal-title":"Immunology"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0685","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0161-5890(01)00006-2","article-title":"Structural and functional properties of membrane and secreted IgD","volume":"37","author":"Preud\u2019homme","year":"2000","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0690","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1684\/ecn.2009.0163","article-title":"Specific increase in caspase-1 activity and secretion of IL-1 family cytokines: a putative link between mevalonate kinase deficiency and inflammation","volume":"20","author":"Normand","year":"2009","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0695","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1182\/blood-2008-03-144667","article-title":"HMG-CoA reductase inhibition induces IL-1 release through Rac1\/PI3K\/PKB-dependent caspase-1 activation","volume":"112","author":"Kuijk","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0700","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.molimm.2007.12.008","article-title":"Statin synergizes with LPS to induce IL-1beta release by THP-1 cells through activation of caspase-1","volume":"45","author":"Kuijk","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0705","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1684\/ecn.2009.0162","article-title":"Pharmacological inhibitors of the mevalonate pathway activate pro-IL-1 processing and IL-1 release by human monocytes","volume":"20","author":"Massonnet","year":"2009","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0710","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/rheumatology\/kes097","article-title":"Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency","volume":"51","author":"Galeotti","year":"2012","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0715","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1136\/ard.2011.149922","article-title":"On-demand anakinra treatment is effective in mevalonate kinase deficiency","volume":"70","author":"Bodar","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0720","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.intimp.2010.03.008","article-title":"Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes","volume":"10","author":"Marcuzzi","year":"2010","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0725","first-page":"469","article-title":"Familial hibernian fever","volume":"51","author":"Williamson","year":"1982","journal-title":"Q. J. Med."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0730","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/art.10429","article-title":"The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome","volume":"46","author":"Dod\u00e9","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0735","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00005792-200209000-00002","article-title":"The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder","volume":"81","author":"Hull","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0740","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/art.24145","article-title":"TNF receptor-associated periodic syndrome (TRAPS): towards a molecular understanding of the systemic autoinflammatory diseases","volume":"60","author":"Ryan","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0745","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.autrev.2012.07.020","article-title":"Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives","volume":"12","author":"Cantarini","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0750","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/art.11215","article-title":"Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes","volume":"48","author":"Aganna","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0755","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/art.33416","article-title":"Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome (TRAPS)","volume":"64","author":"Bulua","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0760","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/art.23475","article-title":"Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome","volume":"58","author":"Gattorno","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0765","doi-asserted-by":"crossref","first-page":"9801","DOI":"10.1073\/pnas.0914118107","article-title":"Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome","volume":"107","author":"Simon","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0770","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.20102049","article-title":"Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS)","volume":"208","author":"Bulua","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0775","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/rheumatology\/kei090","article-title":"Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A","volume":"45","author":"Nowlan","year":"2006","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0780","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1684\/ejd.2010.0951","article-title":"A novel missense mutation in tumour necrosis factor receptor superfamily 1A (TNFRSF1A) gene found in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with high serum interleukin (IL)-22","volume":"20","author":"Nakamura","year":"2010","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0785","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cellimm.2011.02.007","article-title":"Differential cytokine secretion results from p65 and c-Rel NF-(B subunit signaling in peripheral blood mononuclear cells of TNF receptor-associated periodic syndrome patients","volume":"268","author":"Nedjai","year":"2011","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0790","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1056\/NEJMoa0809568","article-title":"An autoinflammatory disease due to homozygous deletion of the IL1RN locus","volume":"360","author":"Reddy","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0795","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","article-title":"An autoinflammatory disease with deficiency of the interleukin-1\u2013receptor antagonist","volume":"360","author":"Aksentijevich","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0800","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1002\/art.30588","article-title":"A novel mutation of IL1RN in the deficiency of interleukin-1 receptor antagonist syndrome: description of two unrelated cases from Brazil","volume":"63","author":"Jesus","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0805","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/archdermatol.2011.3208","article-title":"Interleukin 1 receptor antagonist deficiency presenting as infantile pustulosis mimicking infantile pustular psoriasis","volume":"148","author":"Minkis","year":"2012","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0810","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1002\/art.30565","article-title":"The first reported case of compound heterozygous IL1RN mutations causing deficiency of the interleukin-1 receptor antagonist","volume":"63","author":"Stenerson","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0815","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13256-015-0618-4","article-title":"Interleukin-1 receptor antagonist deficiency with a novel mutation; late onset and successful treatment with canakinumab: a case report","volume":"9","author":"Ulusoy","year":"2015","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0820","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clim.2012.08.003","article-title":"A novel mutation in the interleukin-1 receptor antagonist associated with intrauterine disease onset","volume":"145","author":"Altiok","year":"2012","journal-title":"Clin. Immunol. Orlando Fla."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0825","doi-asserted-by":"crossref","first-page":"P143","DOI":"10.1186\/1546-0096-13-S1-P143","article-title":"Deficiency of interleukin-1 receptor antagonist (DIRA): report of the first Indian patient and a novel deletion affecting IL1RN","volume":"13","author":"Mendonca","year":"2015","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0830","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/excr.1995.1097","article-title":"Synthesis and secretion of interleukin-1 alpha and interleukin-1 receptor antagonist during differentiation of cultured keratinocytes","volume":"217","author":"Corradi","year":"1995","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0835","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-med-061512-150641","article-title":"IL-1 blockade in autoinflammatory syndromes","volume":"65","author":"Jesus","year":"2014","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0840","doi-asserted-by":"crossref","DOI":"10.1111\/j.1525-1470.2012.01725.x","article-title":"Deficiency of interleukin-1 receptor antagonist responsive to anakinra","volume":"30","author":"Schnellbacher","year":"2013","journal-title":"Pediatr. Dermatol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0845","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N. Engl J. Med."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0850","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ajhg.2011.07.022","article-title":"Mutations in IL36RN\/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis","volume":"89","author":"Onoufriadis","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0855","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1182\/blood-2011-05-356873","article-title":"IL-36R ligands are potent regulators of dendritic and T cells","volume":"118","author":"Vigne","year":"2011","journal-title":"Blood."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0860","doi-asserted-by":"crossref","first-page":"e1043","DOI":"10.1542\/peds.2012-3935","article-title":"First clinical description of an infant with interleukin-36-receptor antagonist deficiency successfully treated with anakinra","volume":"132","author":"Rossi-Semerano","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0865","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/jdv.13034","article-title":"A novel mutation in IL36RN underpins childhood pustular dermatosis","volume":"30","author":"Ellingford","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0870","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/ijd.12525","article-title":"IL36RN mutation causing generalized pustular psoriasis in a Palestinian patient","volume":"53","author":"Renert-Yuval","year":"2014","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0875","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2133.2012.10953.x","article-title":"A novel IL36RN\/IL1F5 homozygous nonsense mutation p.Arg10X, in a Japanese patient with adult-onset generalized pustular psoriasis","volume":"167","author":"Sugiura","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0880","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/humu.22203","article-title":"Mutation analysis of the IL36RN gene in 14 Japanese patients with generalized pustular psoriasis","volume":"34","author":"Farooq","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0885","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jid.2016.04.038","article-title":"IL36RN mutations affect protein expression and function: a basis for genotype-phenotype correlation in pustular diseases","volume":"136","author":"Tauber","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0890","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archdermatol.2011.3014","article-title":"DIRA DITRA, and new insights into pathways of skin inflammation","volume":"148","author":"Cowen","year":"2012","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0895","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1084\/jem.20070157","article-title":"Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation","volume":"204","author":"Blumberg","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0900","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1749-6632.2011.06220.x","article-title":"Type I interferonopathies: a novel set of inborn errors of immunity","volume":"1238","author":"Crow","year":"2011","journal-title":"Ann. N. Acad. Sci."},{"key":"10.1016\/j.cytogfr.2016.11.001_bib0905","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","article-title":"The inflammasomes: guardians of the body","volume":"27","author":"Martinon","year":"2009","journal-title":"Annu. Rev. Immunol."}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610116301034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610116301034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T12:50:09Z","timestamp":1601211009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610116301034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":181,"alternative-id":["S1359610116301034"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2016.11.001","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokine signatures in hereditary fever syndromes (HFS)","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2016.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}